DNA And RNA Extraction Market Is Expected To Reach Revenue Of USD 16.4 Bn By 2033, At 8.4% CAGR: Dimension Market Research

(MENAFN- GlobeNewsWire - Nasdaq) Advancements and Projections in the DNA and RNA Extraction Market: Insights, Trends, Opportunities, and Recent Developments

New York, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview

The Global DNA and RNA Extraction Market is projected to reach USD 7.9 billion in 2024 and is expected to grow to USD 16.4 billion by 2033, with a CAGR of 8.4% .

The global DNA & RNA extraction market is also growing at a fast pace in the global level because of development in molecular diagnostics and its growing application in research and clinics.

Catalysed by growing incidence of genetic disorders, increased need for personalised medicines and advancing technologies, the market enjoys the advantages that stem from the existence of automated systems and advances in the biopharmaceutical industry.

Click to Request Sample Report and Drive Impactful Decisions:

Players are Thermo Fisher Scientific, Qiagen, and Merck KGaA; strategies covered are innovation, collaboration, and acquisition. The highest growth is anticipated to be seen in the Asia Pacific area due to added research, government funding, and a developing biotechnology sector.

The US DNA & RNA Extraction Market

The US DNA & RNA extraction market, valued at USD 2.5 billion in 2024, is projected to reach USD 5.0 billion by 2033, growing at a 7.9% CAGR.

It is thus facilitated by growing NGS and PCR utilization, government support for genomic study, and rising biopharmaceutical corporations. Some of the developments include automation as well as the improvement of throughput hence improving the extraction rate .

Businesses are investing in products used in cancer research, detecting infectious diseases, forensic investigations, and many others are backed up by strong research systems for biotechnological innovations.

Important Insights

• Market Value: The global DNA & RNA extraction market is estimated to be worth USD 7.9 billion in 2024, projected to reach USD 16.4 billion by 2033.
• US Market Value: The US DNA & RNA extraction market is valued at USD 2.5 billion in 2024, anticipated to grow to USD 5.0 billion by 2033 at a CAGR of 7.9% .
• Regional Insights: North America is expected to dominate the global DNA & RNA extraction market with a 38.1% share in 2024.
• By Type Segment: DNA extraction is projected to lead the market, holding the highest share based on type in 2024.
• By Product Type Segment: Kits and reagents are expected to dominate the product type segment, accounting for 73.1% of the market share in 2024.
• By Extraction Method Segment : Magnetic bead-based DNA & RNA extraction is forecasted to lead this segment with a 31.5% market share in 2024.
• By Application Segment: Diagnostics is anticipated to hold the highest market share in the application segment in 2024.
• Global Growth Rate: The market is growing at a CAGR of 8.4% over the forecast period.

Latest Trends

• Automation and High-throughput Systems: The extraction market is slowly moving into the automation solutions where the extraction procedures are optimized, and the work of the staff is minimized and much more accurate. Such systems are most effective in the large-scale genomic research and in the clinical diagnostics acting as the driving force for the market.
• Integration of AI and Machine Learning: Currently, features such as AI & Machine learning are also being integrated into the extraction process. They make the data analysis more effective and efficient, improve the genetic data extraction and the usage of genetic data for better diagnostics and for the targeted treatment.

DNA and RNA Extraction Market: Competitive Landscape

The DNA and RNA extraction market comprises of the prominent players like Thermo Fisher Scientific, Qiagen, and Promega Corporation. These companies are instrumental in driving the market through innovations, numerous products and partnerships.

The thermo fisher scientific has varied extraction kit and automation systems, Qiagen is well-known in offering total nucleic acid solutions and Promega offers good quality reagents.

Many products are launched in the market along with acquisitions and continued R&D investments moderate the competitive structure due to emerging needs, regulations, and technology to fuel market growth.

Some of the prominent market players:

• Qiagen
• ThermoFisher Scientific Inc.
• F Hoffmann-La Roche AG
• Agilent Technologies
• Bio-Rad Laboratories Inc.
• Promega Corporation
• Danaher Corporation (Beckman Coulter Inc.)
• Merck & Co. Inc.
• PerkinElmer Inc.
• bioMérieux SA
• Other Key Players

Transform your business approach with strategic insights from our report. Get in touch to request our brochure today! :

DNA and RNA Extraction Market Scope

Report Highlights	Details
Market Size (2024)	USD 7.9 Bn
Forecast Value (2033)	USD 16.4 Bn
CAGR (2024-2033)	8.4%
North America Revenue Share	38.1%
The US Market Size (2024)	USD 2.5 Bn
Historical Data	2018 - 2023
Forecast Data	2024 - 2033
Base Year	2023
Estimate Year	2024
Segments Covered	By Type, By Product Type, By Extraction Method, By Application, and By End User
Regional Coverage	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Market Analysis

Kits and reagents is anticipated to dominate the DNA & RNA extraction market, holding 73.1% of the share in 2024 due to their streamlined and reproducible results. These solutions eliminate many parameters as well as provide high reproducibility, which is highly desirable in high-throughput environments.

Therefore, reagents allow flexibility and possibility of customization according to the types of samples and required tests. Advances in reagent chemistry are characterized by increased yield, purity and cycle time further putting them in a vantage position. D

ue to the simplicity of operation and universality, they have become mandatory for use in clinical diagnostics and biochemical research.

DNA and RNA Extraction Market Segmentation

By Type

• DNA Extraction

• • Genomic DNA Extraction
  • Plasmid DNA Extraction
  • Viral DNA Extraction
  • Total DNA Extraction

• RNA Extraction

• • miRNA Extraction
  • mRNA Extraction
  • Total RNA Extraction
  • Sequence-specific RNA Extraction

By Product Type

• Kits & Reagents
• Instruments

• • Automated Systems
  • Manual Systems
  • Centrifuges
  • Pipettes
  • Magnetic Separators

By Extraction Method

• Magnetic Bead-based Extraction
• Reagent-based Extraction
• Column-based Extraction
• Filtration-based Extraction
• Other Extraction Method

By Application

• Diagnostics
• Precision Medicine
• Drug Discovery & Development
• Agriculture and Animal Research
• Environmental Testing
• Forensic Science
• Other Applications

By End User

• Hospital Laboratories
• Academic & Research Laboratories
• Diagnostic Laboratories
• Biopharmaceutical Companies
• Forensic Laboratories
• Contract Research Organizations (CROs)
• Government Research Institutes

Purchase the Competition Analysis Dashboard Today:

Growth Drivers

• Increasing Prevalence of Genetic Disorders: The increasing frequency of genetic diseases is put into perspective as the driving factor behind the requirement for DNA and RNA extraction. The discovery of the root cause of a specific disease as well as formulating treatment for the genetic diseases drives the market as well as accurate extraction.
• Expanding Applications in Precision Medicine: Modern precision medicine is primarily based on the individual's genetic data. The relevance and accuracy of DNA and RNA extraction and analysis are invaluable for creating individual treatment programs; thus, extraction technologies are becoming more in demand, which stimulates market growth.

Restraints

• High Costs of Advanced Extraction Systems: The cost of such systems, especially the fully automated and high throughput extraction systems, are often beyond the means of small laboratories and even many research institutions. This could reduce the ability to adopt sophisticated extraction techniques, thus reducing market expansion.
• Technical Challenges in Extraction Processes: Methods for the extraction of High Pure Nucleic Acids can sometimes be time-consuming and labor-intensive especially when working with large volumes of samples. These factors include variability in sample quality and the existence of inhibitors for extraction, which have their impacts on efficiency and extraction and therefore pose threats to the markets.

Growth Opportunities

• Emerging Markets in Asia-Pacific: The Asia-Pacific region could be considered highly promising owing to the growing healthcare expenditures and a rising understanding of the Mendelian syndromes as well as leveraging research facilities. Thus, market players can benefit from these opportunities occupying new capacities and providing cheap extraction services.
• Advancements in Synthetic Biology: This is especially the case in the current fast-developing field of synthetic biology where cells contain genetic materials that have to be extracted and modified effectively. Improved technologies in extraction can meet the needs of this dynamic industry to deliver good returns on investment to market participants.

Discover additional reports tailored to your industry needs

• Biopharmaceutical Marke was reached a value of USD 436.7 billion in 2023, and it is further anticipated to reach a market value of USD 1,829.2 billion by 2033 at a CAGR of 15.4%.
• Clinical Trials Market size is expected to reach a market value of USD 96.8 billion in 2024 which is further expected to reach USD 174.3 billion in 2033 at a CAGR of 6.8%.
• Blood Pressure Monitoring Device Market is expected to reach a value of USD 5.7 billion in 2024, and it is further anticipated to reach a market value of USD 13.2 billion by 2033 at a CAGR of 9.8%.
• Amyotrophic Lateral Sclerosis Market size was valued at USD 673.4 million in 2023 and is projected to reach USD 1,271.6 million by 2033, growing at a CAGR of 6.5 % from 2023 to 2033.
• Antibiotics Market reached a value of USD 53.7 billion in 2023, and it is further anticipated to reach a market value of USD 89.2 billion by 2033 at a CAGR of 4.7%.
• Ampicillin Market size is projected to reach a market value of USD 388.1 million by the end of 2024 which is further predicted to reach a value of USD 480.1 million by 2033 at a CAGR of 2.4%.
• Advanced Wound Care Market size was valued at USD 12.3 billion in 2023 and is projected to show subsequent growth with a market value of USD 20.2 billion in 2033 at a CAGR of 5.1%.
• Dental Bone Graft Substitute Market is expected to reach a value of USD 886.4 million by the end of 2024, and it is further anticipated to reach a market value of USD 2,066.8 million by 2033 at a CAGR of 9.9%.

Regional Analysis

North America is projected to dominate the DNA and RNA extraction market, holding 38.1% share in 2024, due to its robust healthcare infrastructure, significant R&D investments, and leading market players like Thermo Fisher Scientific and Qiagen. The regulatory support from bodies such as the FDA helps in aspects of safety as well as speedy assimilation of new products.

High incidence of genetic and infectious diseases increases demand, while the government's support for genomic research and personalized medicine contributes to it. The innovation and precision medicine trends contribute more to market growth and guarantee North America's market leadership.

By Region

North America

• The U.S.
• Canada

Europe

• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe

Asia-Pacific

• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA

Experience Growth: Request Your Sample Copy of the Report Now!

Recent Developments in the DNA and RNA Extraction Market

• July 2024: Bio-Rad Laboratories released DNA extraction kits for single-cell genomics, improving sensitivity and yield for personalized medicine and cancer research.
• June 2024: Thermo Fisher Scientific launched an upgraded automated RNA extraction system with advanced magnetic bead technology for better throughput and accuracy in clinical diagnostics.
• May 2024: Qiagen partnered with a leading genomics company to enhance nucleic acid extraction for precision medicine, integrating their technologies with cutting-edge sequencing platforms.
• April 2024: Promega Corporation introduced a DNA extraction kit for challenging samples, addressing low nucleic acid content and inhibitors, suitable for forensic and environmental applications.
• March 2024: Roche Diagnostics received approval for a rapid viral RNA extraction kit, aiding swift pathogen detection for infectious disease diagnostics.
• January 2024: Illumina increased R&D investments in high-throughput and automated nucleic acid extraction technologies, aiming to improve scalability for research and clinical applications.

About Dimension Market Research (DMR):

Dimension Market Research (DMR) is a market research and consulting firm based in India & US, with its headquarters located in the USA (New York). The company believes in providing the best and most valuable data to its customers using the best resources analysts work, to create unmatchable insights into the industries, and markets while offering in-depth results of over 30 industries, and all major regions across the world.

We also believe that our clients don't always want what they see, so we provide customized reports as well, as per their specific requirements to create the best possible outcomes for them and enhance their business through our data and insights in every possible way.

CONTACT: United States 957 Route 33, Suite 12 #308 Hamilton Square, NJ-08690 Phone No.: +1 732 369 9777, +91 88267 74855 ...

MENAFN19092024004107003653ID1108693474